(SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas

Completed · Not applicable

Conditions studied: Stage IV Adult Soft Tissue Sarcoma, Sarcoma,Soft Tissue

In brief

This is a prospective study to document the local control rates with SBRT specifically for pulmonary metastases from soft tissue sarcoma. This study will prospectively document acute and late toxicity, quality of life (QoL), tumor control, and survival.

Key facts

Study ID

NCT01949506

Run by

Medical College of Wisconsin

People needed

9

Starts

2013-09-24

Expected to finish

2019-10-04

Last updated by the study team

2023-02-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥18 years of age
• Pathologic confirmation of primary soft tissue sarcoma with pathologic or radiographic evidence of pulmonary metastatic disease
• No evidence of extra pulmonary progression of disease for 3 months prior to enrollment on study
• 1-5 pulmonary lesions all ≤5 cm in size
• Medically inoperable or declines surgery
• Patients may have had previous treatment for pulmonary metastases

You may not qualify if…

• Patients who have uncontrolled extra-pulmonary disease
• Pregnant women
• Patients who have greater than 5 pulmonary lesions at the time of study enrollment
• Patients who have disease progression outside the lungs within 3 months of enrollment on the study
• Disease pathology other than sarcoma subtypes
• Patients with a history of metastatic disease from a primary other than sarcoma

Where it is running

• Froedtert Hospital and Medical College of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.